Intimation for appointment of Ms. Shamim Adil Michal as an Additional (Non-Executive Independent) Director of the Company
Announcement under Regulation 30 (LODR)-Change in Directorate
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Supha Pharmachem Ltd on 6ix
Earlier from Supha Pharmachem
- Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, January 22, 2025.
- Supha Pharmachem Ltd Press Release Jan 17 2025
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Supha Pharmachem Ltd Press Release Jan 10 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Supha Pharmachem
- Reconstitution Of Committees Of The Board
- Supha Pharmachem Ltd Press Release Jan 22 2025
- Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Supha Pharmachem Ltd Press Release Jan 24 2025
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem